Exact Mass: 508.1978
Exact Mass Matches: 508.1978
Found 500 metabolites which its exact mass value is equals to given mass value 508.1978
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(7'R,8'R)-4,7'-Epoxy-3'-methoxy-4',5,9,9'-lignanetetrol 9'-glucoside
(7R,8R)-4,7-Epoxy-3-methoxy-4,5,9,9-lignanetetrol 9-glucoside is found in alcoholic beverages. (7R,8R)-4,7-Epoxy-3-methoxy-4,5,9,9-lignanetetrol 9-glucoside is isolated from Riesling wine. Isolated from Riesling wine. (7R,8R)-4,7-Epoxy-3-methoxy-4,5,9,9-lignanetetrol 9-glucoside is found in alcoholic beverages.
6-O-Oleuropeoylsucrose
6-O-Oleuropeoylsucrose is a constituent of the root bark of the olive (Olea europaea). Constituent of the root bark of the olive (Olea europaea)
Belnacasan
Cyclodeca[b]furan-6-carboxylicacid,5-(acetyloxy)-4-[3-(acetyloxy)-2-hydroxy-2-methyl-1-oxobutoxy]-2,3,3a,4,5,8,9,11a-octahydro-10-methyl-3-methylene-2-oxo-,methyl ester (9CI)
Mortonin C
Mortonin D
[7-(hydroxymethyl)-4-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-5-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
(7R,8S)-9,3,9-trihydroxyl-3-methoxyl-7,8-dihydrobenzofuran-1-propylneolignan-4-O-beta-D-glucopyranoside
(7S,8S)-3-methoxy-3,7-epoxy-8,4-oxyneoligna-4,9-diol 9-O-beta-D-glucopyranoside|junipercomnoside C
4-hydroxymethyl-2,6-dimethoxyphenyl 1-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranoside|potalioside A|potalioside B
5,7-Dihydroxy-6-methylflavan-(2beta->7,4beta->8)-7-hydroxy-5-methoxyflavan
(alphaS)-alpha-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-beta-D-ribofuranosyl-4,9-dihydro-3H-imidazo[1,2-alpha]purine-7-butanoic acid methyl ester|(alphaS)-alpha-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-beta-D-ribofuranosyl-4,9-dihydro-3H-imidazo[1,2-a]purine-7-butanoic acid methyl ester|(S)-4--4,6-dimethyl-9-oxo-3-(beta-D-ribofuranosyl)-4,9-dihydro-3H-imidazo<1,2-a>purin-7-yl>butanoic acid methyl ester|wybutosine|yW
Bruceine J
bruceine J is a natural product found in Brucea javanica with data available.
(7R,8R)-3-methoxy-3,7-epoxy-8,4-oxyneoligna-4,9-diol 9-O-beta-D-glucopyranoside|junipercomnoside D
8-hydroxy-(+)-isolariciresinol-9-O-beta-D-xylopyranoside
12-Ketone, 2-butanoyl, 9-Ac-6-Chloro-2, 8, 9, 12-tetrahydroxy-3, 5(16), 13-briaratrien-18, 7-olide
5,4-dihydroxy-3-(alpha-L-rhamnosyl-(1->3)-beta-D-xylopyranosyloxy)bibenzyl|5,4-Dihydroxy-3-??-L-rhamnosyl-(1鈥樏傗垎3)-??-D-xylopyranosyloxybibenzyl
(2R)-2-[(S)-3-hydroxy-3-methylglutaryloxy]putrescine dicinnamamide|pholiotic acid
Asp Phe Val Glu
Val Glu Phe Asp
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
Indacaterol Maleate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Indacaterol maleate (QAB149) is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol maleate inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol maleate can also be used in cardiovascular disease research[1][2].
(5S)-1,7-bis(3,4-dihydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one
Cys Cys Gln Arg
Cys Cys Arg Gln
Cys His Ser Tyr
Cys His Tyr Ser
Cys Lys Met Gln
Cys Lys Gln Met
Cys Met Lys Gln
Cys Met Gln Lys
Cys Met Gln Gln
Cys Asn Ser Trp
Cys Asn Trp Ser
Cys Gln Cys Arg
Cys Gln Lys Met
Cys Gln Met Lys
Cys Gln Met Gln
Cys Gln Gln Met
Cys Gln Arg Cys
Cys Arg Cys Gln
Cys Arg Gln Cys
Cys Ser His Tyr
Cys Ser Asn Trp
Cys Ser Trp Asn
Cys Ser Tyr His
Cys Trp Asn Ser
Cys Trp Ser Asn
Cys Tyr His Ser
Cys Tyr Ser His
Asp Asp Phe Ile
Asp Asp Phe Leu
Asp Asp Ile Phe
Asp Asp Leu Phe
Asp Asp Pro Tyr
Asp Asp Tyr Pro
Asp Glu Phe Val
Asp Glu Val Phe
Asp Phe Asp Ile
Asp Phe Asp Leu
Asp Phe Glu Val
Asp Phe Ile Asp
Asp Phe Leu Asp
Asp Phe Met Pro
Asp Phe Asn Asn
Asp Phe Pro Met
Asp His His Thr
Asp His Thr His
Asp Ile Asp Phe
Asp Ile Phe Asp
Asp Ile Met Met
Asp Leu Asp Phe
Asp Leu Phe Asp
Asp Leu Met Met
Asp Met Phe Pro
Asp Met Ile Met
Asp Met Leu Met
Asp Met Met Ile
Asp Met Met Leu
Asp Met Pro Phe
Asp Asn Phe Asn
Asp Asn Asn Phe
Asp Pro Asp Tyr
Asp Pro Phe Met
Asp Pro Met Phe
Asp Pro Tyr Asp
Asp Thr His His
Asp Val Glu Phe
Asp Val Phe Glu
Asp Tyr Asp Pro
Asp Tyr Pro Asp
Glu Asp Phe Val
Glu Asp Val Phe
Glu Glu Met Thr
Glu Glu Thr Met
Glu Phe Asp Val
Glu Phe Val Asp
Glu His His Ser
Glu His Ser His
Glu Met Glu Thr
Glu Met Met Val
Glu Met Thr Glu
Glu Met Val Met
Glu Pro Thr Tyr
Glu Pro Tyr Thr
Glu Ser His His
Glu Thr Glu Met
Glu Thr Met Glu
Glu Thr Pro Tyr
Glu Thr Tyr Pro
Glu Val Asp Phe
Glu Val Phe Asp
Glu Val Met Met
Glu Tyr Pro Thr
Glu Tyr Thr Pro
Phe Asp Asp Ile
Phe Asp Asp Leu
Phe Asp Glu Val
Phe Asp Ile Asp
Phe Asp Leu Asp
Phe Asp Met Pro
Phe Asp Asn Asn
Phe Asp Pro Met
Phe Asp Val Glu
Phe Glu Asp Val
Phe Glu Val Asp
Phe Ile Asp Asp
Phe Leu Asp Asp
Phe Met Asp Pro
Phe Met Pro Asp
Phe Asn Asp Asn
Phe Asn Asn Asp
Phe Pro Asp Met
Phe Pro Met Asp
Phe Val Asp Glu
Phe Val Glu Asp
His Cys Ser Tyr
His Cys Tyr Ser
His Asp His Thr
His Asp Thr His
His Glu His Ser
His Glu Ser His
His His Asp Thr
His His Glu Ser
His His Ser Glu
His His Thr Asp
His Ser Cys Tyr
His Ser Glu His
His Ser His Glu
His Ser Tyr Cys
His Thr Asp His
His Thr His Asp
His Tyr Cys Ser
His Tyr Ser Cys
Ile Asp Asp Phe
Ile Asp Phe Asp
Ile Asp Met Met
Ile Phe Asp Asp
Ile Met Asp Met
Ile Met Met Asp
Lys Cys Met Gln
Lys Cys Gln Met
Lys Met Cys Gln
Lys Met Gln Cys
Lys Gln Cys Met
Lys Gln Met Cys
Leu Asp Asp Phe
Leu Asp Phe Asp
Leu Asp Met Met
Leu Phe Asp Asp
Leu Met Asp Met
Leu Met Met Asp
Met Cys Lys Gln
Met Cys Gln Lys
Met Cys Gln Gln
Met Asp Phe Pro
Met Asp Ile Met
Met Asp Leu Met
Met Asp Met Ile
Met Asp Met Leu
Met Asp Pro Phe
Met Glu Glu Thr
Met Glu Met Val
Met Glu Thr Glu
Met Glu Val Met
Met Phe Asp Pro
Met Phe Pro Asp
Met Ile Asp Met
Met Ile Met Asp
Met Lys Cys Gln
Met Lys Gln Cys
Met Leu Asp Met
Met Leu Met Asp
Met Met Asp Ile
Met Met Asp Leu
Met Met Glu Val
Met Met Ile Asp
Met Met Leu Asp
Met Met Met Pro
Met Met Asn Asn
Met Met Pro Met
Met Met Val Glu
Met Asn Met Asn
Met Asn Asn Met
Met Pro Asp Phe
Met Pro Phe Asp
Met Pro Met Met
Met Gln Cys Lys
Met Gln Cys Gln
Met Gln Lys Cys
Met Gln Gln Cys
Met Thr Glu Glu
Met Val Glu Met
Met Val Met Glu
Asn Cys Ser Trp
Asn Cys Trp Ser
Asn Asp Phe Asn
Asn Asp Asn Phe
Asn Phe Asp Asn
Asn Phe Asn Asp
Asn Met Met Asn
Asn Met Asn Met
Asn Asn Asp Phe
Asn Asn Phe Asp
Asn Asn Met Met
Asn Ser Cys Trp
Asn Ser Trp Cys
Pro Asp Asp Tyr
Pro Asp Phe Met
Pro Asp Met Phe
Pro Asp Tyr Asp
Pro Glu Thr Tyr
Pro Glu Tyr Thr
Pro Phe Asp Met
Pro Phe Met Asp
Pro Met Asp Phe
Pro Met Phe Asp
Pro Met Met Met
Pro Thr Glu Tyr
Pro Thr Tyr Glu
Pro Tyr Asp Asp
Pro Tyr Glu Thr
Pro Tyr Thr Glu
Gln Cys Cys Arg
Gln Cys Lys Met
Gln Cys Met Lys
Gln Cys Met Gln
Gln Cys Gln Met
Gln Cys Arg Cys
Gln Lys Cys Met
Gln Lys Met Cys
Gln Met Cys Lys
Gln Met Cys Gln
Gln Met Lys Cys
Gln Met Gln Cys
Gln Gln Cys Met
Gln Gln Met Cys
Gln Arg Cys Cys
Arg Cys Cys Gln
Arg Cys Gln Cys
Arg Gln Cys Cys
Ser Glu His His
Ser His Glu His
Ser His His Glu
Thr Asp His His
Thr Glu Glu Met
Thr Glu Met Glu
Thr Glu Pro Tyr
Thr Glu Tyr Pro
Thr His Asp His
Thr His His Asp
Thr Met Glu Glu
Thr Pro Glu Tyr
Thr Pro Tyr Glu
Thr Tyr Glu Pro
Thr Tyr Pro Glu
Val Asp Glu Phe
Val Asp Phe Glu
Val Glu Asp Phe
Val Glu Met Met
Val Phe Asp Glu
Val Phe Glu Asp
Val Met Glu Met
Val Met Met Glu
Tyr Asp Asp Pro
Tyr Asp Pro Asp
Tyr Glu Pro Thr
Tyr Glu Thr Pro
Tyr Pro Asp Asp
Tyr Pro Glu Thr
Tyr Pro Thr Glu
Tyr Ser His Cys
Tyr Thr Glu Pro
Tyr Thr Pro Glu
(7'R,8'R)-4,7'-Epoxy-3'-methoxy-4',5,9,9'-lignanetetrol 9'-glucoside
1,1,3,3,3,3-hexamethylindotricarbocyanine perchlorate
VX-765
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C38461 - Caspase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate
isopropyl ((R)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate
R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-diphenyl-Dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
(ethene-1,1,2,2-tetrayltetrakis(benzene-4,1-diyl))tetraboronic acid
Lonaprisan
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist
L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methylvalyl-N-(2-ethoxytetrahydro-5-oxo-3-furanyl)-
2-[[6-(4-morpholinyl)-4-oxo-3-(2-phenylethyl)-2-quinazolinyl]thio]-N-(2-oxolanylmethyl)acetamide
N-alpha-(2-Naphthylsulfonyl)-N-(3-amidino-L-phenylalaninyl)-D-pipecolinic acid
(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylic acid
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(E)-N-hydroxy-C-(8-methylsulfanyloctyl)carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
N-[4-[[2-methoxy-5-[4-oxo-3-(pyridin-4-ylmethyl)-1,2-dihydroquinazolin-2-yl]phenyl]methoxy]phenyl]acetamide
N-[5-(diethylsulfamoyl)-2-(4-morpholinyl)phenyl]-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[4-[[2-(diethylamino)ethylamino]-oxomethyl]phenyl]-3-[(4-methylphenyl)sulfamoyl]benzamide
(2S,3R,4S)-4-[(E)-2-[1-(2-carboxyethyl)pyridin-1-ium-3-yl]ethenyl]-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
5-[(E)-2-[(2S,3R,4S)-5-carboxy-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]ethenyl]-1-ethylpyridin-1-ium-3-carboxylic acid
5-[(E)-2-[(2S,3R,4S)-3-ethenyl-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]ethenyl]-1-methylpyridin-1-ium-3-carboxylic acid
(7R,8R)-4,7-Epoxy-3-methoxy-4,5,9,9-lignanetetrol 9-glucoside
BI-1622
BI-1622 is an orally active, potent and highly selective HER2 (ERBB2) inhibitor, with an IC50 of 7 nM. BI-1622 shows greater than 25-fold selectivity over EGFR. BI-1622 shows high antitumor efficacy in vivo in xenograft mouse tumor models with engineered H2170 and PC9 cells and had a favorable agent metabolism and pharmacokinetics profile[1].
methyl 5-(acetyloxy)-4-{[3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(2r,3s,4s,5s,6r)-2-{[(1s,4ar,5r,7as)-5-hydroxy-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1r,4as,5s,7ar)-5-hydroxy-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6s)-2-{[(2r,3r)-3-(4-hydroxy-3-methoxyphenyl)-6-(3-hydroxypropyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methoxy}-6-methoxyoxane-3,4,5-triol
(2r,3r,4r,5r,6s)-2-{[(2r,3s,4s,5r)-3,5-dihydroxy-2-{3-hydroxy-5-[2-(4-hydroxyphenyl)ethyl]phenoxy}oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol
2-(hydroxymethyl)-6-{[7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,7ah-cyclopenta[c]pyran-4a-yl]oxy}oxane-3,4,5-triol
1-[(3-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-7-hydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
(1s,2s,4s,5s,6r,9s,12r,17r)-12-isopropyl-1,6-dimethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,8,13-trioxapentacyclo[7.7.1.0²,⁴.0⁶,¹⁷.0¹¹,¹⁶]heptadeca-10,15-diene-7,14-dione
(9r)-3,4,5,19-tetramethoxy-9,10-dimethyl-8-phenoxy-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-9-ol
(2r,3r,4s,5s,6r)-2-{[(2r,3r)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5r)-3,5-dihydroxy-2-{3-hydroxy-5-[2-(4-hydroxyphenyl)ethyl]phenoxy}oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol
(1s,4as,7s,7as)-1-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
2-[4-(hydroxymethyl)-2,6-dimethoxyphenoxy]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1s,4as,5r,7ar)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,7ah-cyclopenta[c]pyran-4a-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5-hydroxy-11-methyl-6-methylidene-16-oxo-12-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadec-13-ene-9-carboxylic acid
(1s,2s,5s)-2-[(1r)-1-carboxy-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2e)-3-phenylprop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}ethyl]-5-methylcyclopentane-1-carboxylic acid
(2r,3s)-2,3-dihydro-7-hydroxy-2-(4'-hydroxy-3'-methoxyphenyl)-3-hydroxymethyl-5-benzo-furanpropanol 4'-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN006465","Ingredient_name": "(2r,3s)-2,3-dihydro-7-hydroxy-2-(4'-hydroxy-3'-methoxyphenyl)-3-hydroxymethyl-5-benzo-furanpropanol 4'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C25H32O11","Ingredient_Smile": "COC1=C(C=CC(=C1)C2C(C3=CC(=CC(=C3O2)O)CCCO)CO)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5633","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s,3r)-2,3-dihydro-7-hydroxy-2-(4'-hydroxy-3'-methoxyphenyl)-3-hydroxymethyl-5-benzo-furanpropanol 4'-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN006622","Ingredient_name": "(2s,3r)-2,3-dihydro-7-hydroxy-2-(4'-hydroxy-3'-methoxyphenyl)-3-hydroxymethyl-5-benzo-furanpropanol 4'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C25H32O11","Ingredient_Smile": "COC1=C(C=CC(=C1)C2C(C3=CC(=CC(=C3O2)O)CCCO)CO)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5634","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,4'-dihydroxy-3-α-l-rhamnosyl-(1''→3')-β-d-xylopyranosyloxybibenzyl
{"Ingredient_id": "HBIN011042","Ingredient_name": "5,4'-dihydroxy-3-\u03b1-l-rhamnosyl-(1''\u21923')-\u03b2-d-xylopyranosyloxybibenzyl","Alias": "NA","Ingredient_formula": "C25H32O11","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(COC(C2O)OC3=CC(=CC(=C3)O)CCC4=CC=C(C=C4)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6107","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-α-l-rhamnopyranosylcatalpol
{"Ingredient_id": "HBIN012634","Ingredient_name": "6-o-\u03b1-l-rhamnopyranosylcatalpol","Alias": "NA","Ingredient_formula": "C21H32O14","Ingredient_Smile": "CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C4C(C=CO3)C(C5C4(O5)CO)O)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18679","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-β-d-apiofuranosyl-mussaenosidicacid
{"Ingredient_id": "HBIN012637","Ingredient_name": "6-o-\u03b2-d-apiofuranosyl-mussaenosidicacid","Alias": "NA","Ingredient_formula": "C21H32O14","Ingredient_Smile": "CC1(CCC2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)COC4C(C(CO4)(CO)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1516","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
alboside i
{"Ingredient_id": "HBIN015087","Ingredient_name": "alboside i","Alias": "NA","Ingredient_formula": "C25H32O11","Ingredient_Smile": "CC1C(CC2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)O","Ingredient_weight": "508.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "867","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100982915","DrugBank_id": "NA"}